Wednesday, January 9, 2013
2:45 pm
153 Noyes, J. Holmes Sturdivant Lecture Hall
Bristol-Myers Squibb Symposium
Pharmaceutical Process Chemistry at Bristol-Myers Squibb and the Preparation of Brivanib Alaninate
Jaan Pesti, Dr., Early Phase Research & Development, Bristol-Myers Squibb
An introduction to the practice of process chemistry with further insights to its manifestation in pharmaceutical chemistry at BMS. The process development of a potential oncology drug, brivanib alaninate, will be described.
Contact Arleen (Lynne) Martinez lynnem@caltech.edu at 4004
Event Sponsors:



05.12.2013 Flickr
05.12.2013 Flickr
05.10.2013 Flickr
04.13.2013 Flickr
04.09.2013 Flickr
04.09.2013 Flickr
03.16.2013 Flickr
03.12.2013 Flickr
02.26.2013 Flickr
02.20.2013 Flickr